Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Bioventus Inc Cl A (BVS)

Bioventus Inc Cl A (BVS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 700,495
  • Shares Outstanding, K 77,147
  • Annual Sales, $ 430,900 K
  • Annual Income, $ 19,380 K
  • 60-Month Beta 2.07
  • Price/Sales 1.51
  • Price/Cash Flow 6.22
  • Price/Book 1.24
Trade BVS with:

Options Overview Details

View History
  • Implied Volatility 105.39% ( -7.40%)
  • Historical Volatility 84.90%
  • IV Percentile 88%
  • IV Rank 54.09%
  • IV High 176.20% on 07/13/22
  • IV Low 21.96% on 08/24/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 45
  • Volume Avg (30-Day) 5
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 257
  • Open Int (30-Day) 234

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 0.19
  • Number of Estimates 2
  • High Estimate 0.21
  • Low Estimate 0.17
  • Prior Year 0.25
  • Growth Rate Est. (year over year) -24.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.30 +44.13%
on 07/13/22
9.31 -2.42%
on 08/03/22
+1.37 (+17.77%)
since 07/12/22
3-Month
6.30 +44.13%
on 07/13/22
10.02 -9.38%
on 06/01/22
+1.03 (+12.80%)
since 05/12/22
52-Week
6.30 +44.13%
on 07/13/22
17.53 -48.20%
on 11/10/21
-6.08 (-40.11%)
since 08/12/21

Most Recent Stories

More News
Bioventus Inc. (BVS) Q2 2022 Earnings Call Transcript

BVS earnings call for the period ending June 30, 2022.

BVS : 9.08 (+7.84%)
Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance

DURHAM, N.C., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active...

BVS : 9.08 (+7.84%)
Aerie Pharmaceuticals (AERI) Reports Q2 Loss, Tops Revenue Estimates

Aerie (AERI) delivered earnings and revenue surprises of 38.46% and 2.59%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

AERI : 11.57 (+4.33%)
BVS : 9.08 (+7.84%)
Bioventus to Report Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022

DURHAM, N.C., July 26, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active...

BVS : 9.08 (+7.84%)
Bioventus Completes CartiHeal Acquisition

DURHAM, N.C., July 12, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active...

BVS : 9.08 (+7.84%)
Bioventus Amends CartiHeal Acquisition Structure

DURHAM, N.C., June 21, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active...

BVS : 9.08 (+7.84%)
Implied Volatility Surging for Bioventus (BVS) Stock Options

Investors need to pay close attention to Bioventus (BVS) stock based on the movements in the options market lately.

BVS : 9.08 (+7.84%)
Bioventus Inc. (BVS) Q1 2022 Earnings Call Transcript

BVS earnings call for the period ending March 31, 2022.

BVS : 9.08 (+7.84%)
Bioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance

DURHAM, N.C., May 10, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active...

BVS : 9.08 (+7.84%)
Bioventus Cancels Proposed $415 Million Offering of Senior Notes; Reaffirms Full-Year 2022 Financial Guidance

DURHAM, N.C., May 03, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active...

BVS : 9.08 (+7.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.

See More

Key Turning Points

3rd Resistance Point 10.28
2nd Resistance Point 9.68
1st Resistance Point 9.38
Last Price 9.08
1st Support Level 8.48
2nd Support Level 7.88
3rd Support Level 7.58

See More

52-Week High 17.53
Fibonacci 61.8% 13.24
Fibonacci 50% 11.92
Fibonacci 38.2% 10.59
Last Price 9.08
52-Week Low 6.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar